NCT04278573View on ClinicalTrials.gov

Intralesional Vitamin D Injection for Treatment of Common Warts

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

April 4, 2023

Study Completion Date

April 4, 2023

Conditions
Warts
Interventions
DRUG

Vitamin D3

Intralesional injection of 0.3 ml 40,000 IU/ml vitamin D3 into one wart

DRUG

Placebo

0.3 ml injection of sterilized sesame oil with no active study ingredient

Trial Locations (1)

55905

Mayo Clinic, Rochester

All Listed Sponsors
lead

Stephen P. Merry

OTHER

NCT04278573 - Intralesional Vitamin D Injection for Treatment of Common Warts | Biotech Hunter | Biotech Hunter